KA
ESRX

Klingman & Associates’s Express Scripts Holding Company ESRX Stock Holding History

Klingman & Associates’s Portfolio ESRX Stock Details ESRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-434
Closed -$31K – 354
2016
Q3 		$31K Hold
434
– – 0.01% 224
2016
Q2 		$33K Hold
434
– – 0.01% 221
2016
Q1 		$30K Hold
434
– – 0.01% 226
2015
Q4 		$38K Hold
434
– – 0.01% 224
2015
Q3 		$35K Hold
434
– – 0.01% 223
2015
Q2 		$39K Hold
434
– – 0.02% 197
2015
Q1 		$38K Buy
434
+162
+60% +$13.6K 0.02% 192
2014
Q4 		$23K Buy
+272
New +$21.3K 0.01% 226

Other funds holding ESRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Klingman & Associates's ESRX Position: Q4 2016 in Review

Klingman & Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2016, closing a stake of 434 shares — an estimated $31K sold.

Klingman & Associates first reported a position in ESRX in Q4 2014 and held it in 8 quarters. The position peaked at $39K in Q2 2015. 1,151 funds tracked by Wall St. Rank hold ESRX as of Q4 2016.

  • Klingman & Associates reported no remaining Express Scripts Holding Company position as of Q4 2016 after selling out during the quarter.
  • Klingman & Associates sold 434 Express Scripts Holding Company shares in Q4 2016, an estimated $31K.
  • Klingman & Associates first reported a position in Express Scripts Holding Company in Q4 2014 and held it in 8 quarters.
  • Klingman & Associates's Express Scripts Holding Company position peaked at $39K in Q2 2015.
  • 1,151 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2016.

Based on Klingman & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.